PA Court Ruling on Consent

Slides:



Advertisements
Similar presentations
Changes in Conditions of Participation (CoPs) and Interpretive Guidelines for Informed Consent Informed Consent The New Requirements Presented by: City-wide.
Advertisements

Licensure Requirements for Cosmetic Laser Procedures By: Vickie L. Mickey, CT,CLHRP.
HIV Exposure: What Emergency Response Agencies Need to Know About Accessing Information.
HOUSE STAFF ORIENTATION 2013 Charles Conklin Director, Risk Management TUHS John R. O’Donnell, Esquire Senior Counsel TUHS.
Universal Protocol for Correct Site Surgery/Procedures and Kaleida Health’s Protocols What is it? How does it apply to you? Who is responsible? When will.
Consent for Research Study A study for patients newly diagnosed with advanced glioblastoma (brain cancer): Learning whether a PET scan with F-fluoromisonidazole.
Obtaining Informed Consent: 1. Elements Of Informed Consent 2. Essential Information For Prospective Participants 3. Obligation for investigators.
Version 6.0 Approved by HIPAA Implementation Team April 14, HIPAA Learning Module The following is an educational Powerpoint presentation on the.
Objective 3.01 Understanding Diagnostic and Therapeutic Services
CHAPTER 3 Informed consent BY; DR. UCHE AMAEFUNA (MD)
ONELEGACY AND CORONER’S CASES Christopher Rogers, M.D. Los Angeles County Coroner.
ACRIN 6657/CALGB Consent for Research Study Contrast-Enhanced Breast MRI and MRS: A Correlative Science Studies to Characterize Tumor Response in.
IRB – Consent Changes 5/29/14. Consent Changes Font = Calibri Clarification and addition to instructions in several sections (Header, Randomization, Voluntary.
Managing Pre-Hospital Exposures PRODUCED BY RI Department of Health, Division of EMS & Hospital Association of Rhode Island.
HOUSE STAFF ORIENTATION 2014 Charles Conklin Director, Risk Management TUHS John R. O’Donnell, Esquire Senior Counsel TUHS.
Implementing a Rapid HIV Testing Guideline for L&D NNEPQIN April 30, 2007.
University of Miami Office of Research Compliance Assessment Lynn E. Smith, JD, CIM, CIP Johanna Stamates, RN, BA, CCRC With assistance from Elizabeth.
A Teaching Hospital Challenge: Balancing Patient Care and Medical Student Education [Insert Name of Presenter] Ethics Resource Center American Medical.
H I P A A T R A I N I N G Self Directed Module 7 Research Disclosures For Data Custodians START Click to begin…
UC DAVIS OFFICE OF RESEARCH Overview of Good Clinical Practices (GCP) Investigator and Study Team Responsibilities Miles McFann IRB Administration Training.
Consent for Research Study A study using 18 F-Fluoride for prostate cancer patients currently enrolled in Dr. Febbo’s “Genomic Guided Therapy” study A.
Consent for Research Study A study for patients newly diagnosed with advanced glioblastoma (brain cancer): Learning whether a PET scan with F-fluoromisonidazole.
IRB  Keep IRB information for each protocol in a separate folder or separate by dividers  All IRB approvals for treatment and stand alone companions.
Investigational Devices and Humanitarian Use Devices June 2007.
Informed Consent Part 1: General Principles Part 2: Risks and Alternatives Related to Central Venous Catheter Insertion Office of Graduate Medical Education.
Legal Aspects of Nursing Part 1
Introduction to Universal Protocol (Pre-Procedure “Time-Out”) Office of Graduate Medical Education Perelman School of Medicine University of Pennsylvania.
Copyright  2000 by Dr. ?????????, Wright State University Dr. ???????? Department of Biomedical, Human Factors, & Industrial Engineering Institutional.
Informed Consent Process Patrick Herbison, MEd, CIP Research Compliance Manager Office of Human Research (OHR)
The TJU Human Research Protection Program (HRPP): Part I – Which Entities/Offices are Involved ? J. Bruce Smith, MD, CIP.
Levels of Review of Research and Quality Improvement Walter Kraft, MD Associate Director, Office of Human Subjects Protection Department of Pharmacology.
SURGICAL FORMS AND RECORDS. TERMINAL OBJECTIVE: Complete selected forms and records.
Contract Language for Family Planning Services Cost Center 802 Benita Decker, RN Family Planning Program Division of Women’s Health Department for Public.
Office of Human Research (OHR) Quality Improvement Program Patrick Herbison Heather Krupinski.
Informed Consent - Documentation Patrick Herbison, MEd, CIP Research Compliance Manager Office of Human Research (OHR)
Clinical Trial Billing and Patient Remuneration
Objectives Upon completion of this training, agencies will be able to:
IRB – Consent Changes 5/29/14
Informed Consent for Transfusion
Patient Care & Ethical Dilemmas
Improving Access to Specialized Services in Québec : Assessment and Outlook (Elective Surgery) Dr Michel Bureau.
HOUSE STAFF ORIENTATION 2016
Stephanie Oppenheimer, MS SUCCESS Center Erica Ellington, CRA, CHRC
2016 Medical Staff Bylaws Proposed Revisions
Consent Coercion Creep Patrick Herbison, MEd, CIP Assistant Director of Compliance Office of Human Research (OHR) These.
FDA’s IDE Decisions and Communications
© 2010 Jones and Bartlett Publishers, LLC
© 2010 Jones and Bartlett Publishers, LLC
HOW TO CONSENT A PATIENT?
Objective 3.01 Understanding Diagnostic and Therapeutic Services
Approaches to Implementing CPT in Your Organization
Top Ten eIRB Application Mistakes
Consent to Medical Care
Common Rule Changes to Consent and Template
Patient Autonomy & Informed consent
Objective 3.01 Understanding Diagnostic and Therapeutic Services
Streamlining IRB Procedures for Expanded Access
Facts about PICC Line Consent Form
Informed Consent (SBER)
Objective 3.01 Understanding Diagnostic and Therapeutic Services
Ethical Considerations for Pediatric Clinical Investigations
Objective 3.01 Understanding Diagnostic and Therapeutic Services
Research, Experimentation, & Clinical Trials
Objective 3.01 Understanding Diagnostic and Therapeutic Services
Objective 3.01 Understanding Diagnostic and Therapeutic Services
Changes to the Common Rule and Single IRB (sIRB)
Objective 3.01 Understanding Diagnostic and Therapeutic Services
Objective 3.01 Understanding Diagnostic and Therapeutic Services
Common Rule Updates Tips and Tricks
Protocol Approval Criteria
Presentation transcript:

PA Court Ruling on Consent Patrick Herbison, MEd, CIP Assistant Director of Compliance Office of Human Research (OHR)

Shinal Case PA Supreme Court: Shinal vs. Toms M.D. – Decided 6/20/2017 (Treatment not Research) Mrs. Shinal suffered injury as a result of brain surgery. Although Dr. Toms indicated that he had discussed the procedures, risks, benefits and alternatives, his physician assistant also discussed aspects of the procedure and obtained consent. The Court Decided: “ . . . a physician may not delegate to others his or her obligation to provide sufficient information in order to obtain a patient’s informed consent.”

Mcare - MEDICAL CARE AVAILABILITY AND REDUCTION OF ERROR ACT When Consent is Required - The following list of procedures is based on Pennsylvania’s Mcare law as applicable to research: Administration of anesthesia Performance of surgical procedures Administration of chemotherapy and radiation Administration of blood and/or human source products Insertion of a surgical device or appliance Performance of any HIV-related testing Administration of an experimental medication, use of an experimental device, use of an approved medication or device in an experimental manner, or removal of bone, fluids or tissue for use in research or in the manufacture of a product. (This would not include leftover tissues from clinical procedures.) Invasive procedures, such as halo placement, central venous catheterization, pulmonary artery catheterization. (Routine needle sticks, such as peripheral intravenous catheter placement, vaccination, and venipuncture are not considered invasive in the context of this policy.)

OHR-8 Consent Form – Investigator Signature (See Next Slide) Decision made in consultation with the Office of Legal Affairs Modify the investigator signature line on the consent form.

PA Court Ruling on Consent In addition, consent must be obtained by a physician per Hospital Policy.

Implementation It is the IRB reviewer’s responsibility to ensure the correct investigator signature option is being used. Policy IC 701 has been revised. New Studies must use new OHR-8. The correct investigator signature text must be added at the time of continuing review. Consent forms do not have to be amended immediately.

OHR-2 and OHR-9 Additions OHR-2 and OHR-9 – New Sections Added Submitter checks: Any Mcare procedures included in the study The proposed investigator signature text IRB Reviewer cross checks the OHR-2/9, the OHR-8, and the protocol to ensure the correct investigator signature option is being used.

Reviewer Form RQ-1 Addition RQ-1 Reviewer Form – Also has a prompt added to check for the correct investigator signature text.

Questions? Comments?